Personalized Approach Shows Survival Benefit in Esophageal Adenocarcinoma
Results of a clinical study called PANGEA (Personalized ANtibodies for GastroEsophageal Adenocarcinoma) found survival benefits for patients when compared to [...]
Best Birthday Gift
A message from ECAN's founder: My husband’s birthday came this week. And this year, for the first time since he [...]
Immunotherapy Breakthroughs for Esophageal Cancer Patients
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) showed significant survival benefits for [...]
Barrett’s Esophagus and Esophageal Adenocarcinoma can run in Families
The familial connection is one of the Strongest Indicators of Risk according to Experts. ECAN spoke with the Leading Researcher [...]
FDA calls New Screening Test Using DNA to Detect Esophageal Cancer a Breakthrough Device
First Time the FDA has given Breakthrough Designation for a Device Targeting Diseases of the Esophagus. Lucid Diagnostics' EsoGuard™ Esophageal [...]
#GivingTuesday Gratitude
ECAN thanks everyone who donated or raised funds to support our medical research campaign on #GivingTuesday! You and the rest [...]
Don’t Be a Turkey!
Thanksgiving is during GERD Awareness Week! Show your gratitude by sharing a life-saving message with someone you are thankful for! [...]
Esophageal Cancer takes the Life of 80’s Rock Icon Eddie Money
Late last month, news broke that Rock Star Eddie Money was diagnosed with Stage IV Esophageal Cancer in the fall [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
Now it's Time to Do It Again! Thanks to thousands in the ECAN family, for the first time in history, [...]
FDA Approves First Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
The U.S. Food and Drug Administration has approved Keytruda (Pembrolizumab) for treatment of advanced Esophageal Squamous Cell Carcinoma (ESCC). It [...]